STOCK TITAN

Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
buybacks

Waystar (Nasdaq: WAY) announced that its Board authorized a share repurchase plan of up to $200 million of common stock. Repurchases may occur over time via open market or other methods, subject to SEC rules. The program is discretionary and may be suspended or discontinued at any time.

Leadership links the authorization to confidence in long-term growth, recurring free cash flow, and a capital allocation framework that balances investment, balance sheet strength, and returning excess capital.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • Authorization to repurchase up to $200 million of common stock
  • Board highlights confidence in long-term growth and recurring free cash flow
  • Plan adds flexibility to return excess capital to shareholders over time

Negative

  • Repurchase plan does not obligate Waystar to buy any shares
  • Execution depends on stock price, financial results, liquidity, and market conditions

Key Figures

Share repurchase authorization: $200 million
1 metrics
Share repurchase authorization $200 million Maximum aggregate amount under new stock repurchase plan

Market Reality Check

Price: $18.55 Vol: Volume 2,449,468 is below...
normal vol
$18.55 Last Close
Volume Volume 2,449,468 is below the 20-day average of 2,771,021, suggesting no pre-news volume spike. normal
Technical Shares at $18.55 are trading below the 200-day MA of $30.96 and sit closer to the 52-week low of $17.89 than the high of $41.49.

Peers on Argus

Sector peers show mixed moves: PRVA +3.22%, DOCS +3.11%, HQY +0.52%, PINC +0.07%...
1 Up

Sector peers show mixed moves: PRVA +3.22%, DOCS +3.11%, HQY +0.52%, PINC +0.07%, while BTSG -4%. Momentum scanner only flags VEEV +2.65%, indicating today’s setup looks more stock-specific than a broad sector rotation.

Historical Context

5 past events · Latest: May 05 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
May 05 Corporate recognition Positive -3.5% Named to TIME100 list and received TIME Impact in AI award.
Apr 29 Earnings report Positive -15.4% Q1 2026 results with double-digit revenue growth and strong margins.
Apr 08 Earnings date notice Neutral -0.9% Announced timing of Q1 2026 results and conference call details.
Apr 07 AI product launch Positive -3.3% Introduced AI solution targeting silent denials and payer take-backs.
Mar 05 AI collaboration Positive -1.3% Expanded Google Cloud collaboration to advance autonomous revenue cycle.
Pattern Detected

Recent positive news (AI launches, strong earnings, awards) often saw negative next-day moves, with 4 of 5 events showing divergence between upbeat headlines and price reaction.

Recent Company History

Over the last six months, Waystar has focused on AI-driven revenue cycle innovation and strong financial execution. On Mar 5 and Apr 7, the company announced AI collaborations and new solutions; on Apr 29, it reported solid Q1 2026 growth and reiterated guidance; and on May 5, it gained TIME100 recognition. Despite generally positive themes, most of these headlines were followed by negative price reactions. Today’s buyback authorization adds a capital-return element to this backdrop of growth and AI investment.

Regulatory & Risk Context

Active S-3 Shelf
Shelf Active
Active S-3 Shelf Registration 2025-07-14

The company has an active S-3ASR shelf registration filed on 2025-07-14, which is effective and has been used at least once via a 424B7 filing on 2025-09-11. The context provided does not include the authorized amount or remaining capacity.

Market Pulse Summary

This announcement introduced a stock repurchase plan authorizing buybacks of up to $200 million of c...
Analysis

This announcement introduced a stock repurchase plan authorizing buybacks of up to $200 million of common stock, framed as a flexible, valuation-focused capital allocation tool. It comes after a series of AI launches, strong quarterly results, and corporate recognition over recent months. Investors may track how actively the authorization is used, overall balance-sheet strength from recent SEC filings, and whether future cash generation supports both growth investments and continued capital returns.

Key Terms

stock repurchase plan, securities and exchange commission, free cash flow, capital allocation
4 terms
stock repurchase plan financial
"announced that its Board of Directors authorized a stock repurchase plan for up to $200 million"
A stock repurchase plan is a company’s program to buy back its own shares from the market, reducing the number of shares available to investors. Like a store buying back its own gift cards to raise the value of remaining cards, buybacks can increase each remaining share’s claim on profits and often signal management believes the stock is undervalued or is an efficient way to return cash, which can affect share price and investor returns.
securities and exchange commission regulatory
"all in accordance with the rules of the Securities and Exchange Commission and other applicable"
A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.
free cash flow financial
"our ability to generate durable, recurring free cash flow," said Matt Hawkins"
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
capital allocation financial
""Our capital allocation priorities are unchanged: invest in product innovation and commercial"
Capital allocation is the process of deciding how a company or individual uses their money to grow, pay bills, save, or invest. It matters because good decisions can help build wealth and ensure resources are used wisely, while poor choices can limit growth or cause financial problems. Think of it like managing your allowance—deciding whether to spend, save, or invest to meet your goals.

AI-generated analysis. Not financial advice.

LEHI, Utah and LOUISVILLE, Ky., May 19, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that its Board of Directors authorized a stock repurchase plan for up to $200 million of the Company's common stock.

Under the stock repurchase plan, the Company may repurchase shares from time to time using a variety of methods, which may include open market purchases or such other methods as the Company may determine, all in accordance with the rules of the Securities and Exchange Commission and other applicable legal requirements. The specific timing, price, and size of purchases will depend on stock price, the Company's financial results and liquidity, general economic and market conditions, and other considerations. The stock repurchase plan does not obligate the Company to acquire any particular amount of common stock, and the Company may suspend or discontinue the stock repurchase plan at any time at its discretion.

"This repurchase authorization reflects our Board's confidence in Waystar's long-term growth, differentiated platform, continued innovation, and our ability to generate durable, recurring free cash flow," said Matt Hawkins, CEO of Waystar. "Our capital allocation priorities are unchanged: invest in product innovation and commercial execution to support durable growth, maintain a strong balance sheet, and return excess capital when we believe it enhances long-term per-share value. This authorization gives us the flexibility to repurchase shares in a disciplined, valuation-focused way as market conditions allow."

Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, the amount, timing, and execution of repurchases under the stock repurchase plan. Forward-looking statements include all statements that are not historical facts. These statements may include words such as "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," "outlook," the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release.

The forward-looking statements contained in this press release are based on management's current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs, and projections will be realized or achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our operation in a highly competitive industry; our ability to retain our existing clients and attract new clients; our ability to successfully execute on our business strategies in order to grow; our ability to accurately assess the risks related to acquisitions and successfully integrate acquired businesses, including the acquisition of Iodine; our ability to establish and maintain strategic relationships; the growth and success of our clients and overall healthcare transaction volumes; consolidation in the healthcare industry; our selling cycle of variable length to secure new client agreements; our implementation cycle that is dependent on our clients' timing and resources; our dependence on our senior management team and certain key employees, and our ability to attract and retain highly skilled employees; the accuracy of the estimates and assumptions we use to determine the size of our total addressable market; our ability to develop and market new solutions, or enhance our existing solutions, to respond to technological changes or evolving industry standards; the interoperability, connectivity, and integration of our solutions with our clients' and their vendors' networks and infrastructures; the performance and reliability of internet, mobile, and other infrastructure; the consequences if we cannot obtain, process, use, disclose, or distribute the highly regulated data we require to provide our solutions; our reliance on certain third-party vendors and providers; any errors or malfunctions in our products and solutions; failure by our clients to obtain proper permissions or provide us with accurate and appropriate information; the potential for embezzlement, identity theft, or other similar illegal behavior by our employees or vendors, and a failure of our employees or vendors to observe quality standards or adhere to environmental, social, and governance standards; our compliance with the applicable rules of the National Automated Clearing House Association and the applicable requirements of card networks; increases in card network fees and other changes to fee arrangements; the effect of payer and provider conduct which we cannot control; privacy concerns and security breaches or incidents relating to our platform or data (including personal information and other regulated data); the complex and evolving laws and regulations regarding privacy, data protection, and cybersecurity; our ability to adequately protect and enforce our intellectual property rights; our ability to use or license data and integrate third-party technologies; the development, deployment, and use of AI; our use of "open source" software; legal proceedings initiated by third parties alleging that we are infringing or otherwise violating their intellectual property rights; claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties; the heavily regulated industry in which we conduct business; the uncertain and evolving healthcare regulatory and political framework; healthcare laws and data privacy and security laws and regulations governing our processing of personal information (which may also be referred to as "personal data" or "personally identifiable information"); reduced revenues in response to changes to the healthcare regulatory landscape; legal, regulatory, and other proceedings that could result in adverse outcomes; contractual obligations requiring compliance with certain provisions of the Bank Secrecy Act/anti-money laundering laws and regulations; existing laws that regulate our ability to engage in certain marketing activities; our full compliance with website accessibility standards; any changes in our tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities; limitations on our ability to use our net operating losses to offset future taxable income; losses due to asset impairment charges; our substantial debt and restrictive covenants in the agreements governing our Credit Facilities; interest rate fluctuations; unavailability of additional capital on acceptable terms or at all; the impact of general macroeconomic conditions; our history of net losses and our ability to achieve or maintain profitability; the interests of certain investors may be different from the interests of other holders of our securities; and each of the other factors discussed under the heading of "Risk Factors" in the Company's 10-K filed with the Securities and Exchange Commission on February 17, 2026, and in other reports filed with the SEC, all of which are available on the Investor Relations page of our website at investors.waystar.com.

Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.

About Waystar 
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves over 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 7.5 billion healthcare payment transactions, including over $2.4 trillion in annual gross claims and spanning approximately 60% of U.S. patients and one in three U.S. hospital discharges. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

Media Contact 
Kristin Lee
kristin.lee@waystar.com

Investor Contact 
investors@waystar.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-announces-200-million-share-repurchase-authorization-reflecting-confidence-in-long-term-outlook-302775615.html

SOURCE Waystar

FAQ

What did Waystar (Nasdaq: WAY) announce on May 19, 2026 about share repurchases?

Waystar announced Board authorization for a share repurchase plan of up to $200 million of common stock. According to Waystar, the company may buy shares over time through open market or other methods, in line with SEC rules and legal requirements.

How large is Waystar's new share buyback authorization and what does it cover for WAY stock?

Waystar's new authorization allows repurchases of up to $200 million of its common stock. According to Waystar, the company can repurchase shares periodically, using open market purchases or other methods, without any obligation to acquire a specific amount of stock.

What does the $200 million Waystar (WAY) buyback mean for shareholders?

The authorization permits Waystar to return excess capital to shareholders by repurchasing up to $200 million of stock. According to Waystar, this fits within priorities to invest in growth, maintain a strong balance sheet, and repurchase shares when it believes valuations support long-term per-share value.

Is Waystar required to repurchase the full $200 million of WAY shares under this plan?

Waystar is not required to repurchase any specific amount of stock under the plan. According to Waystar, the repurchase authorization is discretionary, and the company may suspend or discontinue the program at any time, depending on conditions and its capital allocation priorities.

How will Waystar decide timing and size of share repurchases for WAY stock?

Waystar will base repurchase timing, price, and size on several business and market factors. According to Waystar, decisions will consider stock price, financial results, liquidity, general economic and market conditions, and other considerations, within a disciplined and valuation-focused framework.

Why did Waystar's Board approve a $200 million stock repurchase authorization?

Waystar's Board approved the authorization citing confidence in the company’s long-term prospects and cash generation. According to Waystar, leadership views the plan as consistent with priorities to invest in product innovation, support durable growth, keep a strong balance sheet, and return excess capital when appropriate.